Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
10/14/1999 | WO1999051640A1 Human oxidized ldl receptor |
10/14/1999 | WO1999051596A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051595A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051284A2 Non-covalent bioconjugates useful for diagnosis and therapy |
10/14/1999 | WO1999051275A2 Mesenchymal stem cells as immunosuppressants |
10/14/1999 | WO1999051270A1 A novel nitroreductase and therapeutic uses therefor |
10/14/1999 | WO1999051260A2 Treatment of cardiac hypertrophy |
10/14/1999 | WO1999051248A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases |
10/14/1999 | WO1999051243A1 THE USE OF ESTRADIOL DERIVATIVES FOR TREATING SIDE-EFFECTS DURING AND/OR AFTER GnRHa THERAPY |
10/14/1999 | WO1999051236A1 Methods for inhibiting mrp1 |
10/14/1999 | WO1999051233A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051232A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051231A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | WO1999051228A1 Methods for inhibiting mrp1 |
10/14/1999 | WO1999051227A1 Methods for inhibiting mrp1 |
10/14/1999 | WO1999051225A1 Antidiabetic agents |
10/14/1999 | WO1999051220A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
10/14/1999 | WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
10/14/1999 | WO1999051215A2 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
10/14/1999 | WO1999051186A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
10/14/1999 | WO1999051185A2 Human galactosyl transferases |
10/14/1999 | WO1999051097A1 Compositions containing a combination of a creatine compound and a second agent |
10/14/1999 | WO1999044628A8 Conjugates useful in the treatment of prostate cancer |
10/14/1999 | WO1999044623A8 Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
10/14/1999 | WO1999043809A3 Protease-activated receptor 4 and uses thereof |
10/14/1999 | WO1999043332A8 Antitumor combination comprising epirubicin and gemcitabine for the treatment of non-small-cell lung cancer |
10/14/1999 | WO1999042579A3 Caf1-related protein |
10/14/1999 | WO1999039702A3 Method for regulating size and growth of vascularized normal tissue |
10/14/1999 | WO1999031225A3 Human phosphatases |
10/14/1999 | WO1999026660A3 Conjugates of cytokines and drugs or genes for treating proliferating cells |
10/14/1999 | DE19913089A1 Composition comprising plant extracts from at least two of Bryonia, Ipecacuanha or Drosera, and antimony potassium tartrate, useful for treatment of chronic obstructive pulmonary disease, bronchitis, respiratory disorders and cancer |
10/14/1999 | DE19815060A1 Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie Pharmaceutical preparations for the therapy of side effects during and / or after a GnRHa therapy |
10/14/1999 | DE19814083A1 Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen A process for the production of transdermal therapeutic systems using basic alkali metal salts for the conversion of active substance salts into the free bases |
10/14/1999 | DE19807426A1 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs A method for the treatment of diseases or disorders of the inner ear |
10/14/1999 | CA2328607A1 Antidiabetic agents |
10/14/1999 | CA2327706A1 Methods for inhibiting mrp1 |
10/14/1999 | CA2327652A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
10/14/1999 | CA2327617A1 Methods for inhibiting mrp1 |
10/14/1999 | CA2327452A1 Methods for inhibiting mrp1 |
10/14/1999 | CA2327095A1 Compositions containing a combination of a creatine compound and a second agent |
10/14/1999 | CA2326650A1 Azo and diaza dericatives and uses thereof in phototherapy |
10/14/1999 | CA2326507A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
10/14/1999 | CA2326185A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | CA2326184A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | CA2326143A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | CA2326140A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | CA2325995A1 Antagonists of gonadotropin releasing hormone |
10/14/1999 | CA2325339A1 Dadd, death activator death domain protein |
10/14/1999 | CA2325050A1 A novel nitroreductase and therapeutic uses therefor |
10/14/1999 | CA2325007A1 Human galactosyl transferases |
10/14/1999 | CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
10/14/1999 | CA2324868A1 Human oxidized ldl receptor |
10/13/1999 | EP0949332A2 HSSCRG1 polypeptides |
10/13/1999 | EP0948646A1 Methods for identifying genes essential to the growth of an organism |
10/13/1999 | EP0948632A1 Methods for the characterization and selection of rna target motifs that bind compounds of pharmaceutical use |
10/13/1999 | EP0948627A2 Glutathionylspermidine synthetase |
10/13/1999 | EP0948622A1 Human mage-like protein |
10/13/1999 | EP0948609A2 Llg polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
10/13/1999 | EP0948597A1 HUMAN MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MAdCAM-1) AND SPLICE VARIANTS THEREOF |
10/13/1999 | EP0948510A1 Immunostimulatory nucleic acid molecules |
10/13/1999 | EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
10/13/1999 | EP0948355A1 Treatment of lupus nephritis with anti-cd40l compounds |
10/13/1999 | EP0948349A1 Treatment of inner ear hair cells |
10/13/1999 | EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway |
10/13/1999 | EP0948341A1 Phospholipid drug derivatives |
10/13/1999 | EP0948335A1 Methods of treating or preventing cardiac arrhythmia |
10/13/1999 | EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues |
10/13/1999 | EP0948333A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma |
10/13/1999 | EP0948324A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
10/13/1999 | EP0948323A1 Protease-activated receptor 3 and uses thereof |
10/13/1999 | EP0948308A1 Methods for treating skin pigmentation |
10/13/1999 | EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
10/13/1999 | EP0672192B1 Method for inhibition of viral morphogenesis |
10/13/1999 | EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
10/13/1999 | CN1231609A Antimycotic gel with active substance release |
10/12/1999 | US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides |
10/12/1999 | US5965703 Bcl-x/bcl-2 associated death polypeptide; used for regulating apoptosis in treating acquired immune deficiency syndrome and neurodegenerative diseases; antiischemic agents |
10/12/1999 | US5965618 Treatment of scar tissue using lipoic acid |
10/12/1999 | US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate |
10/12/1999 | US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia |
10/12/1999 | US5965584 Pharmaceutical composition |
10/12/1999 | US5965571 Cholinesterase inhibitors for treatment of Parkinson's disease |
10/12/1999 | US5965551 Method of treating alopecia |
10/12/1999 | US5965540 Antiinflammatory agent |
10/12/1999 | US5965533 Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions |
10/12/1999 | US5965521 Pulsatile delivery of leptin receptor ligands |
10/12/1999 | US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents |
10/12/1999 | US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens |
10/12/1999 | US5965416 Arginyl tRNA synthetase from staphyloccus aureus |
10/12/1999 | US5965396 Human lymph node derived GTPase |
10/12/1999 | US5965392 A nucleic acid molecule; treating obesity or anorexia |
10/12/1999 | US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer |
10/12/1999 | US5965367 Purified bradykinin B1 receptor |
10/12/1999 | US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents |
10/12/1999 | US5965152 Controlled release of miotic and mydriatic drugs in the anterior chamber |
10/12/1999 | US5965133 Self-assembling multimeric nucleic acid constructs |
10/12/1999 | US5965131 Galactosylated clearing agent binds to the primary binding site of the primary targeting species, and only non-bound primary targeting species is cleared, not bound species second site is not blocked by the clearing agent |
10/12/1999 | US5965121 Compounds and compositions for delivering active agents |
10/12/1999 | US5965119 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
10/12/1999 | CA2168732C Gelatin capsules containing a highly concentrated acetaminophen solution |